Clinical Trial Update: Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of lusutrombopag for thrombocytopenia in patients with chronic liver disease undergoing invasive procedures has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• lusutrombopag (lusutrombopag)

Snippet

Sponsor: Shionogi | Conditions: Chronic Liver Disease, Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2018-09-25